Results 141 to 150 of about 7,902,273 (364)
Animal models of hospital-acquired pneumonia: current practices and future perspectives
, 2017 Kenny Bielen +5 more
openalex +1 more source
FEBS Letters, EarlyView.Bone metastasis in prostate cancer (PCa) patients is a clinical hurdle due to the poor understanding of the supportive bone microenvironment. Here, we identify stearoyl‐CoA desaturase (SCD) as a tumor‐promoting enzyme and potential therapeutic target in bone metastatic PCa.
Alexis Wilson +7 more
wiley +1 more source
A Practical Joke in Public Sphere – a Polish Case Study
Styles of Communication, 2017 The aim of the paper is to show multiple layers of discourse and the consequences of a particular practical joke that has been played at a local public event and has become a theme for media coverage nationwide.
Dorota Brzozowska
doaj
Animal welfare in a global perspective [PDF]
, 2009 Global survey of animal-welfare regulations, practices and perceptions, with case studies on poultry meat from Brazil and Thailand, eggs from India and the USA, welfare regulations of farmed fish and welfare aspects related to (perceived) overpopulation ...
Bracke, M.B.M.
core
FEBS Letters, EarlyView.We reconstituted Synechocystis glycogen synthesis in vitro from purified enzymes and showed that two GlgA isoenzymes produce glycogen with different architectures: GlgA1 yields denser, highly branched glycogen, whereas GlgA2 synthesizes longer, less‐branched chains.
Kenric Lee +3 more
wiley +1 more source
β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1
Molecular Oncology, EarlyView.Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero +8 more
wiley +1 more source
Molecular Oncology, EarlyView.PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
Heme Oxygenase-1 Deficiency and Oxidative Stress: A Review of 9 Independent Human Cases and Animal Models [PDF]
, 2021 Akihiro Yachie
openalex +1 more source